Medicines Co. (MDCO) Reports Q3 Loss Per Share of $1.19, Less Than Expected
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts MDCO Hot Sheet
Price: $84.90 --0%
Financial Fact:
Provision for income taxes: -163K
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Provision for income taxes: -163K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Medicines Co. (NASDAQ: MDCO) reported Q3 EPS of ($1.19), $0.25 better than the analyst estimate of ($1.44). Revenue for the quarter came in at $16.9 million versus the consensus estimate of $24.35 million.
For earnings history and earnings-related data on Medicines Co. (MDCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- CPS Technologies (CPSH) Reports In-Line Q3 EPS
- L.B. Foster (FSTR) Reports In-Line Q3 EPS ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
